Revvity | PKI - 税前利润



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 12.21B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


税前利润 更改 日
Agilent USD 364M 78M 2025-12
Align Technology USD 148.89M 27.71M 2026-03
Bio Techne USD 50.78M 34.21M 2025-12
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Celltrion KRW 10.5B 4.1B 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -42M 105M 2026-03
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 9.63B 1.09B 2026-03
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Illumina USD 157M 220M 2026-03
Intuitive Surgical USD 955.6M 100.4M 2025-12
IQVIA Holdings USD 6.22B 5.68B 2026-03
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Laboratory Of America USD 8.73B 8.54B 2026-03
Medical Developments International AUD -149K 466K 2025-06
Mesa Laboratories USD -2.22M 6.03M 2024-12
Mettler Toledo International USD 329.07M 59.84M 2025-12
Myriad Genetics USD 4.6M 3.4M 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
OraSure Technologies USD -18.43M 5.14M 2025-12
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Pharma Mar EUR 1.6M 38.6M 2026-03
Qiagen NV USD 109.17M 25.56M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Quidel USD -79.5M 32.9M 2026-03
Repligen USD 19.11M 2M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Sartorius EUR 157.8M 76.1M 2026-03
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Tilray USD -39.96M 39.19M 2025-09
Waters USD 264.18M 94.06M 2025-12
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03